![Get Involved [Button]](https://fightec.org/wp-content/themes/ecef/images/get-involved_btn.gif)
Cancer-Focused Vivace Emerges with $40M in Financing
A cancer-focused drug discoverer and developer emerged from stealth mode by disclosing today that it has raised $40 million in Series A and Series B financings.
4 Comments4 Responses to Cancer-Focused Vivace Emerges with $40M in Financing
Audiences
Subjects
Categories
Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility
© Copyright 2014. ECEF. All rights reserved.
Leave a Reply